Accumulating clinical experience and technological improvements have provided the basis for transcatheter aortic valve implantation (TAVI) to emerge as a well-established means for treating patients with severe symptomatic aortic stenosis at high or prohibitive surgical risk. During this decade, TAVI has emerged as a valid alternative to surgical aortic valve replacement in patients at intermediate surgical risk, and several studies are currently being performed to evaluate the role of TAVI in patients at low surgical risk. Furthermore, promising, but preliminary, data are emerging on the efficacy of TAVI for treating patients with bicuspid aortic valve disease, as well as patients with pure aortic regurgitation. In this Perspectives article, we summarize the evolving indications for TAVI, and give our opinion on the future perspectives for this procedure.

不断积累的临床经验和技术进步为经导管主动脉瓣植入术（TAVI）的出现奠定了基础，该方法已成为行之有效的方法，可用于治疗具有严重或高手术风险的严重症状性主动脉瓣狭窄的患者。在这十年中，TAVI已成为中等手术风险患者中替代主动脉瓣置换术的有效替代方法，并且目前正在进行多项研究以评估TAVI在低手术风险患者中的作用。此外，关于TAVI治疗二尖瓣主动脉瓣疾病以及纯主动脉瓣反流患者的疗效的有希望的但初步的数据正在涌现。在此“观点”文章中，我们总结了TAVI的发展迹象，